Trazimera

From WikiMD.org
Jump to navigation Jump to search
Trazimera
TermTrazimera
Short definitionTrazimera - (pronounced) (TRA-zih-MAYR-uh) A drug used alone or with other drugs to treat certain types of breast, stomach, and gastroesophageal junction cancer that are HER2 positive. It is also being studied in the treatment of other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Trazimera - (pronounced) (TRA-zih-MAYR-uh) A drug used alone or with other drugs to treat certain types of breast, stomach, and gastroesophageal junction cancer that are HER2 positive. It is also being studied in the treatment of other types of cancer. Trazimera attaches to a protein called HER2, which is found on some cancer cells. This can help the immune system kill cancer cells. Trazimera is a type of monoclonal antibody and a type of HER2 receptor antagonist. Also called Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant and Trastuzumab

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski